February 15, 2017
A Massachusetts federal judge on Wednesday recused herself from a proposed class action by investors claiming they were cheated out of a better deal surrounding Eli Lilly & Co.'s $960 million acquisition of CoLucid Pharmaceuticals Inc., saying counsel Ropes & Gray LLP provides her with legal services.
February 06, 2017
About two weeks after Eli Lilly & Co. announced it was buying migraine treatment developer CoLucid Pharmaceuticals Inc. for $960 million, a CoLucid investor sued Friday in Massachusetts federal court, alleging the two blocked out competing offers and provided a proposed class of investors a subpar share of the deal.